Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stop Retinal Ganglion Cell Dysfunction Study
NCT02390284Phase 3Terminated
- Sponsor
- University of Miami
- Start
- Sep 2015
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of latanoprost, bimatoprost, travoprost, timolol, dorzolamide in Glaucoma, sponsored by University of Miami. Started Sep 2015; status: terminated.
02
Drugs
latanoprostbimatoprosttravoprosttimololdorzolamide
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT02390284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390284.